PBX logo

ProBiotix Health OFEX:PBX Stock Report

Last Price

UK£0.059

Market Cap

UK£10.3m

7D

-9.6%

1Y

-16.1%

Updated

17 Dec, 2024

Data

Company Financials

PBX Stock Overview

Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. More details

PBX fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

ProBiotix Health Plc Competitors

Price History & Performance

Summary of share price highs, lows and changes for ProBiotix Health
Historical stock prices
Current Share PriceUK£0.059
52 Week HighUK£0
52 Week LowUK£0
Beta-0.13
1 Month Change-12.96%
3 Month Change38.24%
1 Year Change-16.07%
3 Year Changen/a
5 Year Changen/a
Change since IPO-73.30%

Recent News & Updates

Recent updates

Shareholder Returns

PBXGB BiotechsGB Market
7D-9.6%-4.6%-1.4%
1Y-16.1%-22.2%4.6%

Return vs Industry: PBX exceeded the UK Biotechs industry which returned -17.4% over the past year.

Return vs Market: PBX underperformed the UK Market which returned 17.5% over the past year.

Price Volatility

Is PBX's price volatile compared to industry and market?
PBX volatility
PBX Average Weekly Movement22.4%
Biotechs Industry Average Movement8.3%
Market Average Movement4.9%
10% most volatile stocks in GB Market10.3%
10% least volatile stocks in GB Market2.6%

Stable Share Price: PBX's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: PBX's weekly volatility has increased from 16% to 22% over the past year.

About the Company

FoundedEmployeesCEOWebsite
20217Steen Andersenprobiotixhealth-ir.com

ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. It offers YourBiotix CH and InstaMelt, capsule formula which contains LPLDL for maintenance of healthy cholesterol; YourBiotix BP, a blood pressure-reducing tablet formula for hypertension and cardiovascular health; and YourBiotix VH, a vascular health capsule formula, indicated to work against the build-up of lipid and calcium deposits in the blood vessels. The company was formerly known as ProBiotix Health Limited and changed its name to ProBiotix Health Plc in February 2022.

ProBiotix Health Plc Fundamentals Summary

How do ProBiotix Health's earnings and revenue compare to its market cap?
PBX fundamental statistics
Market capUK£10.28m
Earnings (TTM)-UK£496.00k
Revenue (TTM)UK£2.13m

4.4x

P/S Ratio

-18.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PBX income statement (TTM)
RevenueUK£2.13m
Cost of RevenueUK£955.00k
Gross ProfitUK£1.17m
Other ExpensesUK£1.67m
Earnings-UK£496.00k

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0031
Gross Margin55.10%
Net Profit Margin-23.32%
Debt/Equity Ratio0%

How did PBX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/17 15:19
End of Day Share Price 2024/12/17 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ProBiotix Health Plc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution